

Genetic and other ancillary tests can be extremely useful resources for pathologists, clinicians, and patients. There are a wide variety of tests used in cancer diagnostics, prognostics, and theranostics. For…
Lumea, the leader in integrated digital pathology, & OptraSCAN, the top end-to-end digital pathology solution provider, announced a collaboration agreement. LEHI, UTAH, UNITED STATES, April 27, 2023 — Lumea, a…
At the medical center of the University of Medicine and Pharmacy in Ho Chi Minh City, patients are not screened for bladder cancer using urine cytology because the pathology department…
Welcome to our first podcast! Today, our guest pathologists Jonhan Ho, MD, and Swikrity U Baskota, MD, share their top three things they didn’t know about becoming an attending pathologist….
The Digital Diagnostic Summit and Lumea are pleased to announce the start of a new pathology podcast: Ask a Pathologist. This podcast is a place where experienced pathologists come together…